Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

NOVEL ANTI-CD30 RECOMBINANT IMMUNOTOXINS CONTAINING DISULFIDE- STABILIZED FV FRAGMENTS

  • Read more about NOVEL ANTI-CD30 RECOMBINANT IMMUNOTOXINS CONTAINING DISULFIDE- STABILIZED FV FRAGMENTS
US Application 60/387,293
Filed on 2002-06-07

Comparative Fluorimetric Hybridization of Consensus Versus Test Sample for the Detection of Known and Unknown Single Nucleotide Variants...

  • Read more about Comparative Fluorimetric Hybridization of Consensus Versus Test Sample for the Detection of Known and Unknown Single Nucleotide Variants...
US Application 60/369,073
Filed on 2002-03-27

METHODS OF DIAGNOSING PROTENTIAL FOR DEVELOPING HEPATOCELLULAR CARCINOMA OR METASTASIS AND IDENTIFYING THERAPEUTIC TARGETS

  • Read more about METHODS OF DIAGNOSING PROTENTIAL FOR DEVELOPING HEPATOCELLULAR CARCINOMA OR METASTASIS AND IDENTIFYING THERAPEUTIC TARGETS
US Application 60/370,895
Filed on 2002-04-05

Rapid Methods and Devices for Detecting and Identifying Biological Agents

  • Read more about Rapid Methods and Devices for Detecting and Identifying Biological Agents
US Application 60/326,930
Filed on 2001-10-03

Apparatus and Method for Multiplex Blotting

  • Read more about Apparatus and Method for Multiplex Blotting
US Application 60/296,475
Filed on 2001-06-06

p-Toluenesulfonhydrazide Derivazation for Separation and Measurement of Endogenous Estrogen Metabolites by High-Performance Liquid...

  • Read more about p-Toluenesulfonhydrazide Derivazation for Separation and Measurement of Endogenous Estrogen Metabolites by High-Performance Liquid...
US Application 60/372,848
Filed on 2002-04-15

Zap70 Protein Expression as a Marker for Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL)

  • Read more about Zap70 Protein Expression as a Marker for Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL)
US Application 60/375,966
Filed on 2002-04-25

Discoidin Domain Receptor 1 Isofirm a (DDR1A) Promotes Migration and Differentiatiation

  • Read more about Discoidin Domain Receptor 1 Isofirm a (DDR1A) Promotes Migration and Differentiatiation
US Application 60/363,734
Filed on 2002-03-12

ELISA Assay of Serum Soluble CD22 To Assess Tumor Burden/Relapse In Patients With B-Cell Leukemia And Lymphoma

  • Read more about ELISA Assay of Serum Soluble CD22 To Assess Tumor Burden/Relapse In Patients With B-Cell Leukemia And Lymphoma
US Application 60/382,269
Filed on 2002-05-20

SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME

  • Read more about SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME
US Application 60/385,371
Filed on 2002-06-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 183
  • Page 184
  • Page 185
  • Page 186
  • Page 187
  • Page 188
  • Page 189
  • Page 190
  • Page 191
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health